Women's health Clinical Trials in New York, NY

As of July 2026, 169 paid clinical trials are recruiting for Women's health in New York, New York. Recruiting Women's health studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

170 clinical trials for Women's health

·Clear filters·↓ Download CSV

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

for Colorectal Cancer

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06096688·Recruiting·Listed Oct 2023

Apply to this trial

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

for Breast Cancer

1 location in New York

Sponsor: Columbia University

Sex: Female·Age: 18+

Code: NCT04824027·Recruiting·Listed Apr 2021

Apply to this trial

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

for Diabetes, Gestational

Sites in New York +4 more locations

Sponsor: Jaeb Center for Health Research

Sex: Female·Age: 18 - 40

Code: NCT06535789·Phase 2, Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

for Breast Cancer

Sites in New York +4 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07205822·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in New York +44 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for Non-small Cell Lung Cancer

Sites in New York +13 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT05877599·Phase 1·Recruiting·Listed May 2023

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in New York +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for Breast Cancer

Drug: Durvalumab

Sites in New York, Stony Brook +31 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06103864·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for Solid Tumor

Sites in New York +6 more locations

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female·Age: 18+

Code: NCT04516447·Phase 1·Recruiting·Listed Aug 2020

Apply to this trial

Conditions in Women's health (New York, NY)

Breast cancer· 99 Ovarian cancer· 44 Endometrial cancer· 36 Cervical cancer· 13 Fallopian tube cancer· 8 Pregnancy· 7 Infertility· 4 Gynecologic cancer· 4 Preeclampsia· 3 Premature / preterm birth· 3 Contraception· 2 Gestational diabetes· 2 Endometriosis· 1 Menopause· 1